East Bay biotech scores $42 million with potential quick-fix for heart trouble

This company wants to make treating an irregular heartbeat as easy as reaching into your backpack, and it’s just raised cash to take the first part of that vision into a mid-stage clinical trial.

East Bay biotech scores $42 million with potential quick-fix for heart trouble



Source

Some local news is curated - Original might have been posted at a different date/ time! Click the source link for details.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.